The IL-23-IL-17 axis in inflammatory arthritis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Shared genetic risk factors and causal association between psoriasis and coronary artery disease.Nature communications · 2022
   Pooled it
2. Distinct immunological signatures in autoimmunity: a multi-plex analysis for the differential diagnosis of established and undifferentiated autoimmune diseases (a cross-sectional pilot study).Rheumatology international · 2026
   Article
3. Role of Nucleotide P2 Receptors in the Immune System: Focus on Effector T Cells.Cells · 2025
   Review
4. Extraintestinal Manifestations ofAntibiotics (Basel, Switzerland) · 2025
   Review
5. Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management.Cellular & molecular biology letters · 2025
   Review
6. IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.iScience · 2025
   Article
7. Mechanisms Underlying the Impact of Interleukin Family on Acute Kidney Injury: Pathogenesis, Progression, and Therapy.Research (Washington, D.C.) · 2025
   Review
8. Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series.RMD open · 2024
   Article
9. Cartilage decellularized matrix hydrogel loaded with protocatechualdehyde for targeted epiphycan treatment of osteoarthritis.Materials today. Bio · 2024
   Article
10. The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities.Rheumatology and therapy · 2024
    Review
11. The star target in SLE: IL-17.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
12. Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms.Metabolic brain disease · 2022
    Article
13. The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment.Medicina (Kaunas, Lithuania) · 2022
    Review
14. A Case Report and Review of the Literature: Reactive Arthritis Caused byFrontiers in microbiology · 2022
    Article
15. Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.Journal of cellular and molecular medicine · 2021
    Article
16. Navigating the diverse immune landscapes of psoriatic arthritis.Seminars in immunopathology · 2021
    Review
17. Anti-IL-23 exerted protective effects on cerebral ischemia-reperfusion injury through JAK2/STAT3 signaling pathway.Molecular biology reports · 2021
    Article
18. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution.Cells · 2021
    Article
19. [Effect of different orthodontic forces on the expression of T helper cell 17 cell-related cytokines in the pressure side of periodontal tissue in rats].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2021
    Article
20. IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.Clinical reviews in allergy & immunology · 2021
    Review

Corrections and comments

• Erratum for
  The IL-23-IL-17 axis in inflammatory arthritis.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract